text
"[""\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023.12.31\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nGS에너지\n비상장\n2012.01.01\n경영참여\n3,499,273\n50,000,000\n100\n3,499,273\n-\n-\n-\n50,000,000\n100\n3,499,273\n15,821,280\n1,014,223\nGS리테일\n상장\n2004.07.01\n경영참여\n311,605\n60,633,923\n57.9\n1,016,275\n-\n-\n-\n60,633,923\n57.9\n1,016,275\n10,042,016\n22,148\nGS스포츠\n비상장\n2004.07.01\n경영참여\n1,999\n600,000\n100\n14,338\n-\n-\n-\n600,000\n100\n14,338\n32,803\n-34\nGS이피에스\n비상장\n2005.11.08\n경영참여\n82,793\n31,373,440\n70\n293,706\n-\n-\n-\n31,373,440\n70\n293,706\n2,533,238\n349,810\nGS글로벌\n상장\n2009.07.01\n경영참여\n103,173\n41,845,884\n50.7\n249,711\n-\n-\n-\n41,845,884\n50.7\n249,711\n1,401,098\n26,079\nGS이앤알\n비상장\n2014.03.01\n경영참여\n565,671\n15,287,093\n87.91\n473,907\n-\n-\n-\n15,287,093\n87.91\n473,907\n3,183,589\n93,053\nGS Beyond Corp\n비상장\n2020.07.03\n경영참여\n6,005\n5,000,000\n100\n6,005\n2,000,000\n2,625\n-\n7,000,000\n100\n8,630\n9,292\n-1,703\nGS Collective Fund I LLC\n비상장\n2020.07.24\n경영참여\n11,985\n55,000,000\n64.52\n68,842\n-\n-\n-\n55,000,000\n64.52\n68,842\n107,400\n8,346\nDione Limited\n비상장\n2021.11.22\n경영참여\n1\n209,519,921\n62.5\n256,404\n-\n-\n-\n209,519,921\n62.5\n256,404\n400,921\n-9,606\nGS벤처스\n비상장\n2022.01.06\n경영참여\n10,000\n2,600,000\n100\n13,000\n-\n-\n-\n2,600,000\n100\n13,000\n13,278\n416\nGS어쌤블신기술투자조합\n비상장\n2022.07.15\n경영참여\n3,000\n6,000\n22.85\n6,000\n3,000\n3,000\n-\n9,000\n22.85\n9,000\n34,761\n-3,106\n인터베스트창업초기투자조합\n비상장\n2020.09.18\n단순투자\n200\n2,000\n5.26\n2,000\n-\n-\n-65\n2,000\n5.26\n1,935\n35,467\n-476\n스마트 LSK 3호 펀드\n비상장\n2020.11.05\n단순투자\n400\n4,000\n7.27\n4,000\n-\n-\n-268\n4,000\n7.27\n3,732\n51,378\n-1,123\n대전규제자유특구 블루포인트 투자펀드\n비상장\n2020.12.24\n단순투자\n1,200\n2,100\n25\n2,100\n900\n900\n559\n3,000\n25\n3,559\n11,394\n-157\nC-Brigde healthcare Fund V\n비상장\n2021.03.19\n단순투자\n1,066\n4,948\n0.6\n4,948\n2,963\n2,963\n2,101\n7,911\n0.6\n10,012\n2,098,787\n76,195\n한국신용데이터\n비상장\n2021.02.18\n단순투자\n1,000\n72,471\n0.71\n5,688\n-\n-\n-3,753\n72,471\n0.71\n1,935\n188,515\n-27,913\n비마이프렌즈\n비상장\n2021.03.02\n단순투자\n1,000\n14,167\n6.78\n2,000\n-\n-\n-\n14,167\n6.44\n2,000\n24,729\n-6,975\nGuardian ScaleUp Fund\n비상장\n2021.05.21\n단순투자\n262\n1,088\n7.14\n1,088\n-14\n-14\n-\n1,074\n7.14\n1,074\n14,199\n-1,055\nInnovation Endeavors IV\n비상장\n2021.06.14\n단순투자\n564\n1,947\n1\n1,947\n656\n656\n-\n2,603\n1\n2,603\n294,699\n3,334\nSofinnova Industrial Biotech II\n비상장\n2021.08.05\n단순투자\n339\n1,024\n4\n1,024\n773\n773\n-\n1,797\n2.85\n1,797\n58,736\n-3,649\nHILLHOUSE CLIMATE FUND FEEDER, L.P.\n비상장\n2021.09.27\n단순투자\n2,268\n3,199\n2.15\n3,199\n3,221\n3,221\n-1,013\n6,420\n2.15\n5,407\n273,308\n-3,762\n인비저닝클라이밋솔루션투자조합\n비상장\n2021.09.28\n단순투자\n1,050\n2,450\n9.11\n2,450\n1,680\n1,680\n-235\n4,130\n9.11\n3,895\n41,992\n-1,509\n큐티스바이오\n비상장\n2021.12.06\n단순투자\n1,000\n11,236\n3.28\n1,000\n-\n-\n-\n11,236\n3.08\n1,000\n4,188\n-1,084\nRecarbon Inc.\n비상장\n2021.12.09\n단순투자\n1,176\n1,787,630\n0.93\n1,176\n-\n-\n-1,176\n1,787,630\n0.73\n-\n15,972\n-19,645\n리코\n비상장\n2021.12.14\n단순투자\n1,000\n3,732\n6.4\n6,002\n-\n-\n-\n3,732\n5.94\n6,002\n16,758\n-4,201\n토기\n비상장\n2021.12.21\n단순투자\n1,000\n17,826\n4.95\n1,000\n-\n-\n-1,000\n17,826\n4.95\n-\n1,646\n-570\n바이오오케스트라\n비상장\n2022.02.18\n단순투자\n6,000\n135,691\n1.32\n6,000\n-\n-\n-\n135,691\n1.32\n6,000\n55,856\n-13,274\n퓨처이브이\n비상장\n2022.03.07\n단순투자\n500\n4,045\n3.33\n500\n-\n-\n-\n4,045\n3.17\n500\n1,699\n-720\n사이프러스트리 에프피 엔코어 신기술사업투자조합\n비상장\n2022.04.07\n단순투자\n6,000\n6,000\n7.69\n6,902\n-\n-\n1,213\n6,000\n7.69\n8,115\n77,654\n-525\nLowercarobn 7.81,LP\n비상장\n2022.04.29\n단순투자\n578\n1,421\n2.1\n1,421\n1,733\n1,733\n-\n3,154\n2.1\n3,154\n162,462\n-342\nCornell Capital Partners Fund II LP\n비상장\n2022.05.25\n단순투자\n4,362\n6,821\n0.92\n6,821\n5,088\n5,088\n-375\n11,909\n0.92\n11,534\n787,678\n-66,541\nRVAC\n비상장\n2022.04.19\n\xa0단순투자\xa0\n12,328\n1,666,666\n1.92\n12,328\n-\n-\n-11,323\n1,666,666\n1.92\n1,005\n123,106\n-4,256\nGREEN LI_ION PTE, LTD\n비상장\n2022.04.25\n\xa0단순투자\xa0\n373\n1,103\n0.49\n373\n-\n-\n-\n1,103\n0.41\n373\n48,834\n-3,382\n임팩트 피크닉 투자조합\n비상장\n2022.09.15\n\xa0단순투자\xa0\n400\n400\n7.77\n400\n400\n397\n-28\n800\n7.77\n769\n9,943\n-164\nSpider Capital Partners III, L.P.\n비상장\n2022.07.27\n\xa0단순투자\xa0\n314\n314\n6.85\n314\n809\n809\n-\n1,123\n5.48\n1,123\n16,021\n-2,173\n주식회사 마키나락스\n비상장\n2022.04.25\n\xa0단순투자\xa0\n3,000\n21,755\n1.38\n3,000\n-\n-\n-\n21,755\n1.35\n3,000\n13,536\n-4,835\n주식회사 누비랩\n비상장\n2022.04.25\n\xa0단순투자\xa0\n1,000\n63,910\n1.86\n1,000\n-\n-\n-\n63,910\n1.86\n1,000\n9,865\n-1,857\n데일리크릭바이오 헬스케어 펀드\n비상장\n2022.11.25\n\xa0단순투자\xa0\n200\n200\n0.4\n200\n400\n400\n-33\n600\n2.07\n567\n9,463\n-474\n에스디티 주식회사\n비상장\n2023.03.23\n\xa0단순투자\xa0\n1,500\n-\n-\n-\n1,500\n1,500\n-\n1,500\n2.14\n1,500\n15,288\n-3,756\nSOSV V LP\n비상장\n2023.02.24\n\xa0단순투자\xa0\n1,043\n-\n-\n-\n1,581\n1,581\n-\n1,581\n4.34\n1,581\n39,575\n-1,265\nGeltor, Inc.\n비상장\n2023.05.05\n\xa0단순투자\xa0\n2,678\n-\n-\n-\n0\n2,678\n-\n-\n-\n2,678\n69,107\n-10,746\nACV Capital V L.P.\n비상장\n2023.04.17\n\xa0단순투자\xa0\n708\n-\n-\n-\n1,060\n1,060\n-\n1,060\n1.43\n1,060\n24,814\n-2,026\n주식회사 레브잇\n비상장\n2023.06.21\n\xa0단순투자\xa0\n2,000\n-\n-\n-\n1,999\n1,999\n-\n1,999\n0.56\n1,999\n76,909\n-11,024\nEdamama\n비상장\n2023.06.21\n단순투자\n1,304\n-\n-\n-\n0\n1,304\n-\n-\n-\n1,304\n16,424\n-10,777\nCarbon Direct Fund II LP\n비상장\n2023.07.12\n단순투자\n1,872\n-\n-\n-\n2,111\n2,111\n-\n2,111\n1.24\n2,111\n142,135\n9,128\nZordi, Inc.\n비상장\n2023.08.03\n단순투자\n1,293\n-\n-\n-\n1,293\n1,293\n-\n1,293\n-\n1,293\n10,237\n-6,770\nDebut Biotechnology, Inc. Series B\n비상장\n2023.08.23\n단순투자\n6,693\n-\n-\n-\n89,288\n6,693\n-\n89,288\n2.78\n6,693\n72,322\n-13,487\nTriple W Ltd., Series B\n비상장\n2023.09.08\n단순투자\n1,333\n-\n-\n-\n19,610\n1,333\n-\n19,610\n2.04\n1,333\n10,533\n-11,292\n아이엠엠 Japan 핵심기술 벤처펀드 제1호\n비상장\n2023.11.14\n\xa0단순투자\n1,000\n-\n-\n-\n1,000\n1,000\n-\n1,000\n23.5\n1,000\n4,321\n56\n합 계\n-\n-\n5,976,342\n-\n46,783\n-15,396\n-\n-\n6,007,729\n38,509,226\n1,346,574\n※ '최근사업연도 재무현황' 수치는 2023년 사업연도말 연결기준 재무현황 수치이며, 일부 법인의 경우 현실적으로 자료 확보가 불가능하여 \xa0아래의 재무정보를 바탕으로 작성하였습니다. 1) 2023년 3분기 기준 \xa0- 한국신용데이터, Innovation Endeavors IV, Sofinnova Industrial Biotech II, HILLHOUSE CLIMATE FUND FEEDER, L.P., Lowercarobn 7.81,LP, Cornell Capital Partners Fund II LP, Spider Capital Partners III, L.P., SOSV V LP, Debut Biotechnology, Inc. , Triple W\xa0Ltd.,  2) 2023년 1분기 기준 \xa0- 인터베스트창업초기투자조합, 대전규제자유특구 블루포인트 투자펀드, 비마이프렌즈, 큐티스바이오, 리코, 토기, 바이오오케스트라, 퓨처이브이, 사이프러스트리에프피 엔코어 신기술사업투자조합, RVAC, 임팩트 피크닉 투자조합, 주식회사마키나락스, 주식회사 누비랩, 데일리크릭바이오 헬스케어 펀드, 에스디티 주식회사, Geltor, Inc., 주식회사 레브잇 3) 2022년 사업연도 기준 \xa0- ACV Capital V L.P※ 당사는 기업회계기준에 따라 공정가치측정금융상품에 대해서는 공정가치 측정을 진행하고 있으며, 종속기업, 관계기업 투자주식에 대해서는 손상징후를 검토하고 징후가 있을 경우 해당 자산 회수가능액을 추정하여 손상 회계처리 하고 있습니다. \n""]"
